{
  "name": "Alligator Bioscience",
  "slug": "alligator-bioscience",
  "description": "Statiskt källarkiv med kurshistorik, finansiella rapporter och regulatoriska dokument. För nordiska bolag används Nasdaq Nordic primärt och MFN endast för saknade rapportperioder.",
  "status": "complete",
  "updated_at": "2026-08-07T00:53:05Z",
  "nasdaq_status": "retrieved",
  "latest_market": "2026-08-06: stängning 0.0404, volym 9424228",
  "mfn_status": "resolved_no_reports",
  "mfn_count": 0,
  "nasdaq_reports_status": "retrieved",
  "reports": {
    "available": true,
    "url": "/company/alligator-bioscience/reports",
    "count": 16,
    "nasdaq_count": 16,
    "mfn_fallback_count": 0,
    "items": [
      {
        "report_key": "2026:q1",
        "period_label": "2026 Q1",
        "date": "2026-05-05",
        "title": "Kvartalsrapport Q1 2026",
        "original_title": "Alligator Bioscience AB reports financial results for the period 1 January - 31 March 2026 and provides a business update",
        "category": "Interim report (Q1 and Q3)",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=bd1471d46077f5b7838b400ec9bdddbb8&lang=en&src=listed",
        "language": "en",
        "report_type": "interim-report",
        "fiscal_year": 2026,
        "quarter": "q1",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2026",
            "title": "Kvartalsrapport Q1 2026",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/afbb9d8d7be332ccffec0525d92709386",
            "date": "2026-05-05",
            "period": "2026-q1",
            "form_type": "interim-report",
            "report_key": "2026:q1",
            "filename": "2026_Q1_EN_VF.pdf",
            "text_chars": 72994,
            "sha256": "c173b55c9b92ad0f5bf034ffc6a3d85100a5273744339b8bcd328bd6850fb28d",
            "url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
            "absolute_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
            "txt_url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q1-2026/part-001.html",
                "chars": 72994
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2025:annual",
        "period_label": "2025 Årsredovisning",
        "date": "2026-03-26",
        "title": "Årsredovisning 2025",
        "original_title": "Alligator Bioscience publicerar årsredovisning för 2025",
        "category": "Bokslut och Verksamhetsberättelse",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b9bd11e3e670ec21cc8b03a3ab6d3cbb5&lang=sv&src=listed",
        "language": "sv",
        "report_type": "annual-report",
        "fiscal_year": 2025,
        "quarter": "annual",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-arsredovisning-2025",
            "title": "Årsredovisning 2025",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/ad641651bcd9bc5c20804648bc0d2e9a0",
            "date": "2026-03-26",
            "period": "2025-annual",
            "form_type": "annual-report",
            "report_key": "2025:annual",
            "filename": "AR_2025_SV_VF.pdf",
            "text_chars": 345423,
            "sha256": "91f91f7ceb320969331497cb41f02223304c190217337f3abcfc4ec60a05a8ed",
            "url": "/company/alligator-bioscience/documents/nasdaq-nordic-arsredovisning-2025",
            "absolute_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-arsredovisning-2025",
            "txt_url": "/company/alligator-bioscience/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/alligator-bioscience/documents/nasdaq-nordic-arsredovisning-2025/part-001.html",
                "chars": 175937
              },
              {
                "number": 2,
                "url": "/company/alligator-bioscience/documents/nasdaq-nordic-arsredovisning-2025/part-002.html",
                "chars": 169484
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2025:q4",
        "period_label": "2025 Q4",
        "date": "2026-02-12",
        "title": "Kvartalsrapport Q4 2025",
        "original_title": "Alligator Bioscience AB presenterar finansiella resultat för året och fjärde kvartalet 2025 och ger en affärsuppdatering",
        "category": "Bokslutskommuniké",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b7a5e5f5bc6e8085c3db6f16b3f258757&lang=sv&src=listed",
        "language": "sv",
        "report_type": "year-end-report",
        "fiscal_year": 2025,
        "quarter": "q4",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2025",
            "title": "Kvartalsrapport Q4 2025",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a79224ea811094732bc66868aaec083b3",
            "date": "2026-02-12",
            "period": "2025-q4",
            "form_type": "year-end-report",
            "report_key": "2025:q4",
            "filename": "2025_Q4_SE_VF.pdf",
            "text_chars": 86169,
            "sha256": "9c94521745c3e6d8e6f6738c57a822ab08268220dedbb0d3d8f8f9dd379c55a8",
            "url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
            "absolute_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
            "txt_url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q4-2025/part-001.html",
                "chars": 86169
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2025:q3",
        "period_label": "2025 Q3",
        "date": "2025-10-23",
        "title": "Kvartalsrapport Q3 2025",
        "original_title": "Alligator Bioscience AB reports financial results for Q3 2025 and provides a business update",
        "category": "Interim report (Q1 and Q3)",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=bd1e869f804f050dcac5f545f86c5a5ba&lang=en&src=listed",
        "language": "en",
        "report_type": "interim-report",
        "fiscal_year": 2025,
        "quarter": "q3",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2025",
            "title": "Kvartalsrapport Q3 2025",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/ad325535825e91a50cc23d9f41b696fbb",
            "date": "2025-10-23",
            "period": "2025-q3",
            "form_type": "interim-report",
            "report_key": "2025:q3",
            "filename": "2025_Q3_EN.pdf",
            "text_chars": 81271,
            "sha256": "f00fa60821773923862360e1a450dc872f198d3e6ebca104fe0ab2c0538bc9f2",
            "url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q3-2025",
            "absolute_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q3-2025",
            "txt_url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q3-2025/part-001.html",
                "chars": 81271
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2025:q2",
        "period_label": "2025 Q2",
        "date": "2025-07-10",
        "title": "Kvartalsrapport Q2 2025",
        "original_title": "Alligator Bioscience AB presenterar finansiella resultat för det andra kvartalet 2025 och ger en affärsuppdatering",
        "category": "Halvårsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b4c3af77b9afa83ffe9bc7b1e1b835d0e&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2025,
        "quarter": "q2",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2025",
            "title": "Kvartalsrapport Q2 2025",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/ac495709d3fe84446d2f04dcec1586d62",
            "date": "2025-07-10",
            "period": "2025-q2",
            "form_type": "interim-report",
            "report_key": "2025:q2",
            "filename": "2025_Q2_SE_V1_0.pdf",
            "text_chars": 76107,
            "sha256": "216095aef7d87c9b99d9458b8069c8bc2f010ca514ec5a9f6eef2b84e1c14a28",
            "url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
            "absolute_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
            "txt_url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q2-2025/part-001.html",
                "chars": 76107
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2025:q1",
        "period_label": "2025 Q1",
        "date": "2025-04-24",
        "title": "Kvartalsrapport Q1 2025",
        "original_title": "Alligator Bioscience AB reports financial results for Q1 2025 and provides a business update",
        "category": "Interim report (Q1 and Q3)",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b14bba0d65d18dea977f21552e9265738&lang=en&src=listed",
        "language": "en",
        "report_type": "interim-report",
        "fiscal_year": 2025,
        "quarter": "q1",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2025",
            "title": "Kvartalsrapport Q1 2025",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a5cdbfaa7c79ad9e62fde2758ea8d6f1a",
            "date": "2025-04-24",
            "period": "2025-q1",
            "form_type": "interim-report",
            "report_key": "2025:q1",
            "filename": "2025_Q1_EN_VF.pdf",
            "text_chars": 72834,
            "sha256": "fb12b3215d4cf16ff7b5ecc26ac016af02c4317b428849b60d4f9a64df7a8b9d",
            "url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q1-2025",
            "absolute_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q1-2025",
            "txt_url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q1-2025/part-001.html",
                "chars": 72834
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2024:annual",
        "period_label": "2024 Årsredovisning",
        "date": "2025-03-27",
        "title": "Årsredovisning 2024",
        "original_title": "Alligator Bioscience publicerar årsredovisning för 2024",
        "category": "Bokslut och Verksamhetsberättelse",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=bf9a7bc0ba90da9324b65403cd49e6e2c&lang=sv&src=listed",
        "language": "sv",
        "report_type": "annual-report",
        "fiscal_year": 2024,
        "quarter": "annual",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-arsredovisning-2024",
            "title": "Årsredovisning 2024",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/ac2da60a0a0edcae413b97efdc3451f44",
            "date": "2025-03-27",
            "period": "2024-annual",
            "form_type": "annual-report",
            "report_key": "2024:annual",
            "filename": "Alligator_Annual_Report_2024_SE_VF.pdf",
            "text_chars": 293277,
            "sha256": "070896377b3e7557b350de90c8d3d93dc4be0f2a60704fb7b3a3fb560d902757",
            "url": "/company/alligator-bioscience/documents/nasdaq-nordic-arsredovisning-2024",
            "absolute_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-arsredovisning-2024",
            "txt_url": "/company/alligator-bioscience/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/alligator-bioscience/documents/nasdaq-nordic-arsredovisning-2024/part-001.html",
                "chars": 177073
              },
              {
                "number": 2,
                "url": "/company/alligator-bioscience/documents/nasdaq-nordic-arsredovisning-2024/part-002.html",
                "chars": 116202
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2024:q4",
        "period_label": "2024 Q4",
        "date": "2025-01-22",
        "title": "Kvartalsrapport Q4 2024",
        "original_title": "Alligator Bioscience AB presenterar finansiella resultat för året och fjärde kvartalet 2024 och ger en affärsuppdatering",
        "category": "Bokslutskommuniké",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b2f3ef5a4cef4f8df1f2e21f2a2366dc1&lang=sv&src=listed",
        "language": "sv",
        "report_type": "year-end-report",
        "fiscal_year": 2024,
        "quarter": "q4",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2024",
            "title": "Kvartalsrapport Q4 2024",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a7d940865ecfd823495e7172af5e02f93",
            "date": "2025-01-22",
            "period": "2024-q4",
            "form_type": "year-end-report",
            "report_key": "2024:q4",
            "filename": "2024Q4_SE_22_Jan_2025_VF.pdf",
            "text_chars": 79267,
            "sha256": "b169634a23686a5edd24adfe9340090e451f284f380fceff260c39d4486dbf34",
            "url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
            "absolute_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
            "txt_url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q4-2024/part-001.html",
                "chars": 79267
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2024:q3",
        "period_label": "2024 Q3",
        "date": "2024-10-24",
        "title": "Kvartalsrapport Q3 2024",
        "original_title": "Alligator Bioscience AB presenterar finansiella resultat för de första nio månaderna och Q3 2024, samt ger en affärsuppdatering",
        "category": "Interimsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b1a1f46c2d33278338de6b90c923a6139&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2024,
        "quarter": "q3",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2024",
            "title": "Kvartalsrapport Q3 2024",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/ac61f8f772e309a8f16a981a9a9fa8526",
            "date": "2024-10-24",
            "period": "2024-q3",
            "form_type": "interim-report",
            "report_key": "2024:q3",
            "filename": "2024Q3_SE_Oct_2024_VF.pdf",
            "text_chars": 78173,
            "sha256": "755ae192c82e79fc222bbafcaa3fd14e0164b1905abf0c268f753509fad4509c",
            "url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q3-2024",
            "absolute_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q3-2024",
            "txt_url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q3-2024/part-001.html",
                "chars": 78173
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2024:q2",
        "period_label": "2024 Q2",
        "date": "2024-07-11",
        "title": "Kvartalsrapport Q2 2024",
        "original_title": "Alligator Bioscience AB presenterar finansiella resultat i delårsrapport för H1 2024 och Q2 2024 och ger en affärsuppdatering",
        "category": "Halvårsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=baf4a2fa047a50e7f5e0d0164aa925e6b&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2024,
        "quarter": "q2",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2024",
            "title": "Kvartalsrapport Q2 2024",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a7a64c862daa42128331c5f84bf3a9042",
            "date": "2024-07-11",
            "period": "2024-q2",
            "form_type": "interim-report",
            "report_key": "2024:q2",
            "filename": "2024Q2_SE_Jul_2024_VF.pdf",
            "text_chars": 84937,
            "sha256": "9524a48d0f6d3b1d86a73d6ad340c18e16062940bd7f90440e920dae6b6a4968",
            "url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
            "absolute_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
            "txt_url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q2-2024/part-001.html",
                "chars": 84937
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2024:q1",
        "period_label": "2024 Q1",
        "date": "2024-06-25",
        "title": "Kvartalsrapport Q1 2024",
        "original_title": "Alligator Bioscience offentliggör finansiering om upp till 80 MSEK som förlänger kassalikviditet till Q1 2025",
        "category": "Insiderinformation",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=bb1f84f57234d7da35f9fc34f087dc3ba&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2024,
        "quarter": "q1",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2024",
            "title": "Kvartalsrapport Q1 2024",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a0418f29b7964250d1218fd7ca0bec65a",
            "date": "2024-06-25",
            "period": "2024-q1",
            "form_type": "interim-report",
            "report_key": "2024:q1",
            "filename": "Alligator_Bioscience_offentliggor_finansiering_om_upp_till_80_MSEK_som_forlanger_kassalikviditet.pdf",
            "text_chars": 17268,
            "sha256": "c299967224e7a88dba9dd77f3eac8d21e53a4d57e59e07c92ef7ab6415bd63c8",
            "url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q1-2024",
            "absolute_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q1-2024",
            "txt_url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q1-2024/part-001.html",
                "chars": 17268
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2023:annual",
        "period_label": "2023 Årsredovisning",
        "date": "2024-03-21",
        "title": "Årsredovisning 2023",
        "original_title": "Alligator Bioscience publicerar årsredovisning för 2023",
        "category": "Bokslut och Verksamhetsberättelse",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b0a6b05c3a44a0ee36dc44a40090e12da&lang=sv&src=listed",
        "language": "sv",
        "report_type": "annual-report",
        "fiscal_year": 2023,
        "quarter": "annual",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-arsredovisning-2023",
            "title": "Årsredovisning 2023",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a54e1a37bc80719993d2e8beed9beae4c",
            "date": "2024-03-21",
            "period": "2023-annual",
            "form_type": "annual-report",
            "report_key": "2023:annual",
            "filename": "Arsredovisning_2023_SE_VF.pdf",
            "text_chars": 339343,
            "sha256": "c766b06f29432d33d063e3e709ba5af42c077b3a05b0271711d31a020f0c93d1",
            "url": "/company/alligator-bioscience/documents/nasdaq-nordic-arsredovisning-2023",
            "absolute_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-arsredovisning-2023",
            "txt_url": "/company/alligator-bioscience/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/alligator-bioscience/documents/nasdaq-nordic-arsredovisning-2023/part-001.html",
                "chars": 178917
              },
              {
                "number": 2,
                "url": "/company/alligator-bioscience/documents/nasdaq-nordic-arsredovisning-2023/part-002.html",
                "chars": 160424
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2023:q4",
        "period_label": "2023 Q4",
        "date": "2024-02-08",
        "title": "Kvartalsrapport Q4 2023",
        "original_title": "Alligator Bioscience AB presenterar finansiella resultat för året och fjärde kvartalet 2023 och ger en affärsuppdatering",
        "category": "Bokslutskommuniké",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b9f7a570a12566cd199becfa8484c5264&lang=sv&src=listed",
        "language": "sv",
        "report_type": "year-end-report",
        "fiscal_year": 2023,
        "quarter": "q4",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2023",
            "title": "Kvartalsrapport Q4 2023",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a411c4a9955c484db62fdbab71c8c1d17",
            "date": "2024-02-08",
            "period": "2023-q4",
            "form_type": "year-end-report",
            "report_key": "2023:q4",
            "filename": "2023Q4_SE_Feb_2024_VF.pdf",
            "text_chars": 82098,
            "sha256": "54d93871fa5928040ca2179275bceefe1a82ed2dfd0d467dcbd0fc2b88ca0b6e",
            "url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
            "absolute_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
            "txt_url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q4-2023/part-001.html",
                "chars": 82098
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2023:q3",
        "period_label": "2023 Q3",
        "date": "2023-10-26",
        "title": "Kvartalsrapport Q3 2023",
        "original_title": "Alligator Bioscience AB presenterar finansiella resultat för de första nio månaderna och Q3 2023 och ger en affärsuppdatering",
        "category": "Interimsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b2aeab80dc53e99c2810bab8c43d15dd0&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2023,
        "quarter": "q3",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2023",
            "title": "Kvartalsrapport Q3 2023",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/aa9c670249a94a7369ab5b56dbe1eef38",
            "date": "2023-10-26",
            "period": "2023-q3",
            "form_type": "interim-report",
            "report_key": "2023:q3",
            "filename": "2023Q3_SE_26_Oct_2023_VF.pdf",
            "text_chars": 85634,
            "sha256": "2aa2586e1590c14d0201385822bfb79d46bae364d1ff1df2cce24fedad9dc893",
            "url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q3-2023",
            "absolute_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q3-2023",
            "txt_url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q3-2023/part-001.html",
                "chars": 85634
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2023:q2",
        "period_label": "2023 Q2",
        "date": "2023-07-13",
        "title": "Kvartalsrapport Q2 2023",
        "original_title": "Alligator Bioscience AB presenterar finansiella resultat i delårsrapport för H1 2023 och Q2 2023 och ger en affärsuppdatering",
        "category": "Halvårsrapport",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b004911fa503d838e3a273505e6367153&lang=sv&src=listed",
        "language": "sv",
        "report_type": "interim-report",
        "fiscal_year": 2023,
        "quarter": "q2",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2023",
            "title": "Kvartalsrapport Q2 2023",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/a2ae94d904f1f265f0a56f55900d13643",
            "date": "2023-07-13",
            "period": "2023-q2",
            "form_type": "interim-report",
            "report_key": "2023:q2",
            "filename": "Q22023_SE_13_Jul_2023_VF.pdf",
            "text_chars": 81119,
            "sha256": "8b7b30cbb8cee4b22351ec733762410190dfa2e08bf7e87aacc76d96a4487fb2",
            "url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
            "absolute_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
            "txt_url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q2-2023/part-001.html",
                "chars": 81119
              }
            ]
          }
        ],
        "alternatives": []
      },
      {
        "report_key": "2023:q1",
        "period_label": "2023 Q1",
        "date": "2023-04-25",
        "title": "Kvartalsrapport Q1 2023",
        "original_title": "Alligator Bioscience AB reports financial results for Q1 2023 and provides a business update",
        "category": "Interim report (Q1 and Q3)",
        "source": "Nasdaq Nordic",
        "source_class": "nasdaq-report",
        "source_url": "https://view.news.eu.nasdaq.com/view?id=b2e4b66fbc08126eb49c218ccb64bedcc&lang=en&src=listed",
        "language": "en",
        "report_type": "interim-report",
        "fiscal_year": 2023,
        "quarter": "q1",
        "documents": [
          {
            "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2023",
            "title": "Kvartalsrapport Q1 2023",
            "source": "Nasdaq Nordic",
            "source_class": "nasdaq-report",
            "source_url": "https://attachment.news.eu.nasdaq.com/aa2de2744337c59d8ae5942a44827bc5d",
            "date": "2023-04-25",
            "period": "2023-q1",
            "form_type": "interim-report",
            "report_key": "2023:q1",
            "filename": "Q12023_EN_25_Apr_2023.pdf",
            "text_chars": 72407,
            "sha256": "1982e9615a90b794d2dd42d787bc82f1eea842ed773ccf4e19c7e6606e56bd50",
            "url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q1-2023",
            "absolute_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q1-2023",
            "txt_url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt",
            "absolute_txt_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt",
            "parts": [
              {
                "number": 1,
                "url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q1-2023/part-001.html",
                "chars": 72407
              }
            ]
          }
        ],
        "alternatives": []
      }
    ]
  },
  "report_count": 16,
  "nasdaq_report_count": 16,
  "mfn_fallback_count": 0,
  "sec_status": "skipped",
  "sec_count": 0,
  "fi_status": "retrieved",
  "fi_summary": {
    "company": "Alligator Bioscience",
    "identity": {
      "issuer": "Alligator Bioscience AB",
      "lei": "549300E15VI0MB7LXV19",
      "source": "FI aggregerade blankningspositioner",
      "row_count": 25,
      "score": 118.0,
      "status": "resolved",
      "requested_company": "Alligator Bioscience",
      "query": "Alligator Bioscience AB",
      "candidate_count": 346
    },
    "period": {
      "from": "2024-08-07",
      "to": "2026-08-07",
      "years": 2
    },
    "generated_at": "2026-08-07T00:53:05Z",
    "insider": {
      "transactions": 31,
      "all_export_rows": 31,
      "acquisitions": 7,
      "disposals": 1,
      "other": 23,
      "acquisition_value_sek": 4794539.62,
      "disposal_value_sek": 179045.31,
      "characters": {
        "Avyttring": 1,
        "Förvärv": 7,
        "Gåva lämnad": 2,
        "Lösen minskning": 7,
        "Lösen ökning": 4,
        "Teckning": 8,
        "Tilldelning": 2
      }
    },
    "short_selling": {
      "aggregate_percent": 1.87,
      "current_public_positions": 1,
      "historical_changes": 55,
      "current_position_sum_over_0_5": 1.87
    },
    "sources": {
      "insider_register": "https://www.fi.se/sv/vara-register/insynsregistret/",
      "short_register": "https://www.fi.se/sv/vara-register/blankningsregistret/"
    }
  },
  "warnings": [
    "MFN fallback: resolved_no_reports"
  ],
  "source_identity": {
    "nasdaq_reports": {
      "slug": "",
      "instrument_id": "TX2227504",
      "resolved_url": "https://www.nasdaq.com/european-market-activity/shares/atorx?id=TX2227504"
    },
    "mfn": {
      "status": "resolved",
      "company_name": "Alligator Bioscience",
      "expected_name": "Alligator Bioscience",
      "match_score": 100.0,
      "slug": "alligator-bioscience",
      "url": "https://mfn.se/all/a/alligator-bioscience",
      "metadata": {
        "country": "Sverige",
        "list": "Small Cap Stockholm",
        "sector": "Hälsovård",
        "industry": "Bioteknik",
        "website": "https://alligatorbioscience.se/en/"
      },
      "ticker_candidates": [],
      "attempts": []
    },
    "sec": null,
    "nasdaq": {
      "instrument_id": "TX2227504",
      "asset_class": "SHARES",
      "isin": "SE0024173637",
      "symbol": "ATORX",
      "company": "Alligator Bioscience",
      "market": null,
      "last_sale_price": "SEK 0.0404",
      "time_as_of": "2026-08-06"
    },
    "finansinspektionen": {
      "issuer": "Alligator Bioscience AB",
      "lei": "549300E15VI0MB7LXV19",
      "source": "FI aggregerade blankningspositioner",
      "row_count": 25,
      "score": 118.0,
      "status": "resolved",
      "requested_company": "Alligator Bioscience",
      "query": "Alligator Bioscience AB",
      "candidate_count": 346
    }
  },
  "documents": [
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2026",
      "title": "Kvartalsrapport Q1 2026",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/afbb9d8d7be332ccffec0525d92709386",
      "date": "2026-05-05",
      "period": "2026-q1",
      "form_type": "interim-report",
      "report_key": "2026:q1",
      "filename": "2026_Q1_EN_VF.pdf",
      "text_chars": 72994,
      "sha256": "c173b55c9b92ad0f5bf034ffc6a3d85100a5273744339b8bcd328bd6850fb28d",
      "url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
      "absolute_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q1-2026",
      "txt_url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q1-2026/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q1-2026/part-001.html",
          "chars": 72994
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-arsredovisning-2025",
      "title": "Årsredovisning 2025",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/ad641651bcd9bc5c20804648bc0d2e9a0",
      "date": "2026-03-26",
      "period": "2025-annual",
      "form_type": "annual-report",
      "report_key": "2025:annual",
      "filename": "AR_2025_SV_VF.pdf",
      "text_chars": 345423,
      "sha256": "91f91f7ceb320969331497cb41f02223304c190217337f3abcfc4ec60a05a8ed",
      "url": "/company/alligator-bioscience/documents/nasdaq-nordic-arsredovisning-2025",
      "absolute_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-arsredovisning-2025",
      "txt_url": "/company/alligator-bioscience/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-arsredovisning-2025/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/alligator-bioscience/documents/nasdaq-nordic-arsredovisning-2025/part-001.html",
          "chars": 175937
        },
        {
          "number": 2,
          "url": "/company/alligator-bioscience/documents/nasdaq-nordic-arsredovisning-2025/part-002.html",
          "chars": 169484
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2025",
      "title": "Kvartalsrapport Q4 2025",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a79224ea811094732bc66868aaec083b3",
      "date": "2026-02-12",
      "period": "2025-q4",
      "form_type": "year-end-report",
      "report_key": "2025:q4",
      "filename": "2025_Q4_SE_VF.pdf",
      "text_chars": 86169,
      "sha256": "9c94521745c3e6d8e6f6738c57a822ab08268220dedbb0d3d8f8f9dd379c55a8",
      "url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
      "absolute_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q4-2025",
      "txt_url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q4-2025/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q4-2025/part-001.html",
          "chars": 86169
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2025",
      "title": "Kvartalsrapport Q3 2025",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/ad325535825e91a50cc23d9f41b696fbb",
      "date": "2025-10-23",
      "period": "2025-q3",
      "form_type": "interim-report",
      "report_key": "2025:q3",
      "filename": "2025_Q3_EN.pdf",
      "text_chars": 81271,
      "sha256": "f00fa60821773923862360e1a450dc872f198d3e6ebca104fe0ab2c0538bc9f2",
      "url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q3-2025",
      "absolute_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q3-2025",
      "txt_url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q3-2025/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q3-2025/part-001.html",
          "chars": 81271
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2025",
      "title": "Kvartalsrapport Q2 2025",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/ac495709d3fe84446d2f04dcec1586d62",
      "date": "2025-07-10",
      "period": "2025-q2",
      "form_type": "interim-report",
      "report_key": "2025:q2",
      "filename": "2025_Q2_SE_V1_0.pdf",
      "text_chars": 76107,
      "sha256": "216095aef7d87c9b99d9458b8069c8bc2f010ca514ec5a9f6eef2b84e1c14a28",
      "url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
      "absolute_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q2-2025",
      "txt_url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q2-2025/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q2-2025/part-001.html",
          "chars": 76107
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2025",
      "title": "Kvartalsrapport Q1 2025",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a5cdbfaa7c79ad9e62fde2758ea8d6f1a",
      "date": "2025-04-24",
      "period": "2025-q1",
      "form_type": "interim-report",
      "report_key": "2025:q1",
      "filename": "2025_Q1_EN_VF.pdf",
      "text_chars": 72834,
      "sha256": "fb12b3215d4cf16ff7b5ecc26ac016af02c4317b428849b60d4f9a64df7a8b9d",
      "url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q1-2025",
      "absolute_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q1-2025",
      "txt_url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q1-2025/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q1-2025/part-001.html",
          "chars": 72834
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-arsredovisning-2024",
      "title": "Årsredovisning 2024",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/ac2da60a0a0edcae413b97efdc3451f44",
      "date": "2025-03-27",
      "period": "2024-annual",
      "form_type": "annual-report",
      "report_key": "2024:annual",
      "filename": "Alligator_Annual_Report_2024_SE_VF.pdf",
      "text_chars": 293277,
      "sha256": "070896377b3e7557b350de90c8d3d93dc4be0f2a60704fb7b3a3fb560d902757",
      "url": "/company/alligator-bioscience/documents/nasdaq-nordic-arsredovisning-2024",
      "absolute_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-arsredovisning-2024",
      "txt_url": "/company/alligator-bioscience/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-arsredovisning-2024/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/alligator-bioscience/documents/nasdaq-nordic-arsredovisning-2024/part-001.html",
          "chars": 177073
        },
        {
          "number": 2,
          "url": "/company/alligator-bioscience/documents/nasdaq-nordic-arsredovisning-2024/part-002.html",
          "chars": 116202
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2024",
      "title": "Kvartalsrapport Q4 2024",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a7d940865ecfd823495e7172af5e02f93",
      "date": "2025-01-22",
      "period": "2024-q4",
      "form_type": "year-end-report",
      "report_key": "2024:q4",
      "filename": "2024Q4_SE_22_Jan_2025_VF.pdf",
      "text_chars": 79267,
      "sha256": "b169634a23686a5edd24adfe9340090e451f284f380fceff260c39d4486dbf34",
      "url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
      "absolute_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q4-2024",
      "txt_url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q4-2024/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q4-2024/part-001.html",
          "chars": 79267
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2024",
      "title": "Kvartalsrapport Q3 2024",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/ac61f8f772e309a8f16a981a9a9fa8526",
      "date": "2024-10-24",
      "period": "2024-q3",
      "form_type": "interim-report",
      "report_key": "2024:q3",
      "filename": "2024Q3_SE_Oct_2024_VF.pdf",
      "text_chars": 78173,
      "sha256": "755ae192c82e79fc222bbafcaa3fd14e0164b1905abf0c268f753509fad4509c",
      "url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q3-2024",
      "absolute_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q3-2024",
      "txt_url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q3-2024/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q3-2024/part-001.html",
          "chars": 78173
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2024",
      "title": "Kvartalsrapport Q2 2024",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a7a64c862daa42128331c5f84bf3a9042",
      "date": "2024-07-11",
      "period": "2024-q2",
      "form_type": "interim-report",
      "report_key": "2024:q2",
      "filename": "2024Q2_SE_Jul_2024_VF.pdf",
      "text_chars": 84937,
      "sha256": "9524a48d0f6d3b1d86a73d6ad340c18e16062940bd7f90440e920dae6b6a4968",
      "url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
      "absolute_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q2-2024",
      "txt_url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q2-2024/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q2-2024/part-001.html",
          "chars": 84937
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2024",
      "title": "Kvartalsrapport Q1 2024",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a0418f29b7964250d1218fd7ca0bec65a",
      "date": "2024-06-25",
      "period": "2024-q1",
      "form_type": "interim-report",
      "report_key": "2024:q1",
      "filename": "Alligator_Bioscience_offentliggor_finansiering_om_upp_till_80_MSEK_som_forlanger_kassalikviditet.pdf",
      "text_chars": 17268,
      "sha256": "c299967224e7a88dba9dd77f3eac8d21e53a4d57e59e07c92ef7ab6415bd63c8",
      "url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q1-2024",
      "absolute_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q1-2024",
      "txt_url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q1-2024/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q1-2024/part-001.html",
          "chars": 17268
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-arsredovisning-2023",
      "title": "Årsredovisning 2023",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a54e1a37bc80719993d2e8beed9beae4c",
      "date": "2024-03-21",
      "period": "2023-annual",
      "form_type": "annual-report",
      "report_key": "2023:annual",
      "filename": "Arsredovisning_2023_SE_VF.pdf",
      "text_chars": 339343,
      "sha256": "c766b06f29432d33d063e3e709ba5af42c077b3a05b0271711d31a020f0c93d1",
      "url": "/company/alligator-bioscience/documents/nasdaq-nordic-arsredovisning-2023",
      "absolute_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-arsredovisning-2023",
      "txt_url": "/company/alligator-bioscience/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-arsredovisning-2023/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/alligator-bioscience/documents/nasdaq-nordic-arsredovisning-2023/part-001.html",
          "chars": 178917
        },
        {
          "number": 2,
          "url": "/company/alligator-bioscience/documents/nasdaq-nordic-arsredovisning-2023/part-002.html",
          "chars": 160424
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q4-2023",
      "title": "Kvartalsrapport Q4 2023",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a411c4a9955c484db62fdbab71c8c1d17",
      "date": "2024-02-08",
      "period": "2023-q4",
      "form_type": "year-end-report",
      "report_key": "2023:q4",
      "filename": "2023Q4_SE_Feb_2024_VF.pdf",
      "text_chars": 82098,
      "sha256": "54d93871fa5928040ca2179275bceefe1a82ed2dfd0d467dcbd0fc2b88ca0b6e",
      "url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
      "absolute_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q4-2023",
      "txt_url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q4-2023/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q4-2023/part-001.html",
          "chars": 82098
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q3-2023",
      "title": "Kvartalsrapport Q3 2023",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/aa9c670249a94a7369ab5b56dbe1eef38",
      "date": "2023-10-26",
      "period": "2023-q3",
      "form_type": "interim-report",
      "report_key": "2023:q3",
      "filename": "2023Q3_SE_26_Oct_2023_VF.pdf",
      "text_chars": 85634,
      "sha256": "2aa2586e1590c14d0201385822bfb79d46bae364d1ff1df2cce24fedad9dc893",
      "url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q3-2023",
      "absolute_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q3-2023",
      "txt_url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q3-2023/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q3-2023/part-001.html",
          "chars": 85634
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q2-2023",
      "title": "Kvartalsrapport Q2 2023",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/a2ae94d904f1f265f0a56f55900d13643",
      "date": "2023-07-13",
      "period": "2023-q2",
      "form_type": "interim-report",
      "report_key": "2023:q2",
      "filename": "Q22023_SE_13_Jul_2023_VF.pdf",
      "text_chars": 81119,
      "sha256": "8b7b30cbb8cee4b22351ec733762410190dfa2e08bf7e87aacc76d96a4487fb2",
      "url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
      "absolute_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q2-2023",
      "txt_url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q2-2023/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q2-2023/part-001.html",
          "chars": 81119
        }
      ]
    },
    {
      "doc_id": "nasdaq-nordic-kvartalsrapport-q1-2023",
      "title": "Kvartalsrapport Q1 2023",
      "source": "Nasdaq Nordic",
      "source_class": "nasdaq-report",
      "source_url": "https://attachment.news.eu.nasdaq.com/aa2de2744337c59d8ae5942a44827bc5d",
      "date": "2023-04-25",
      "period": "2023-q1",
      "form_type": "interim-report",
      "report_key": "2023:q1",
      "filename": "Q12023_EN_25_Apr_2023.pdf",
      "text_chars": 72407,
      "sha256": "1982e9615a90b794d2dd42d787bc82f1eea842ed773ccf4e19c7e6606e56bd50",
      "url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q1-2023",
      "absolute_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q1-2023",
      "txt_url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q1-2023/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/alligator-bioscience/documents/nasdaq-nordic-kvartalsrapport-q1-2023/part-001.html",
          "chars": 72407
        }
      ]
    },
    {
      "doc_id": "mfn-mfn-bolagssida-och-bolagsmetadata",
      "title": "MFN bolagssida och bolagsmetadata",
      "source": "MFN",
      "source_class": "mfn",
      "source_url": "https://mfn.se/all/a/alligator-bioscience",
      "date": null,
      "period": null,
      "form_type": "company-page",
      "report_key": null,
      "filename": "company.txt",
      "text_chars": 13634,
      "sha256": "4a4f0730b0ef54118a478159e4762ff2409c394388660ad2952f98d2ae929892",
      "url": "/company/alligator-bioscience/documents/mfn-mfn-bolagssida-och-bolagsmetadata",
      "absolute_url": "https://spela.port0.org/company/alligator-bioscience/documents/mfn-mfn-bolagssida-och-bolagsmetadata",
      "txt_url": "/company/alligator-bioscience/documents/mfn-mfn-bolagssida-och-bolagsmetadata/fulltext.txt",
      "absolute_txt_url": "https://spela.port0.org/company/alligator-bioscience/documents/mfn-mfn-bolagssida-och-bolagsmetadata/fulltext.txt",
      "parts": [
        {
          "number": 1,
          "url": "/company/alligator-bioscience/documents/mfn-mfn-bolagssida-och-bolagsmetadata/part-001.html",
          "chars": 13634
        }
      ]
    }
  ],
  "market_files": [
    {
      "label": "Nasdaq kurshistorik CSV",
      "url": "/company/alligator-bioscience/market/history.csv",
      "absolute_url": "https://spela.port0.org/company/alligator-bioscience/market/history.csv"
    },
    {
      "label": "Nasdaq kurshistorik JSON",
      "url": "/company/alligator-bioscience/market/history.json",
      "absolute_url": "https://spela.port0.org/company/alligator-bioscience/market/history.json"
    },
    {
      "label": "Nasdaq manifest JSON",
      "url": "/company/alligator-bioscience/market/manifest.json",
      "absolute_url": "https://spela.port0.org/company/alligator-bioscience/market/manifest.json"
    },
    {
      "label": "Nasdaq instrumentidentitet JSON",
      "url": "/company/alligator-bioscience/market/instrument.json",
      "absolute_url": "https://spela.port0.org/company/alligator-bioscience/market/instrument.json"
    },
    {
      "label": "MFN manifest JSON",
      "url": "/company/alligator-bioscience/market/mfn-manifest.json",
      "absolute_url": "https://spela.port0.org/company/alligator-bioscience/market/mfn-manifest.json"
    },
    {
      "label": "Nasdaq rapportmanifest JSON",
      "url": "/company/alligator-bioscience/market/nasdaq-reports-manifest.json",
      "absolute_url": "https://spela.port0.org/company/alligator-bioscience/market/nasdaq-reports-manifest.json"
    }
  ],
  "sec_facts": {
    "status": "missing",
    "metrics": []
  },
  "morningstar": {
    "configured": false,
    "status": "inte hämtad",
    "captured_at": null,
    "view_count": 0,
    "url": "/company/alligator-bioscience/morningstar"
  },
  "finansinspektionen": {
    "available": true,
    "status": "retrieved",
    "url": "/company/alligator-bioscience/finansinspektionen",
    "transaction_count": 31,
    "aggregate_short_percent": 1.87,
    "files": [
      {
        "filename": "summary.json",
        "label": "Sammanfattning JSON",
        "url": "summary.json"
      },
      {
        "filename": "insider-transactions.csv",
        "label": "Insynstransaktioner CSV",
        "url": "insider-transactions.csv"
      },
      {
        "filename": "insider-transactions.json",
        "label": "Insynstransaktioner JSON",
        "url": "insider-transactions.json"
      },
      {
        "filename": "short-current.json",
        "label": "Aktuella blankningspositioner JSON",
        "url": "short-current.json"
      },
      {
        "filename": "short-history.json",
        "label": "Historiska blankningspositioner JSON",
        "url": "short-history.json"
      },
      {
        "filename": "short-aggregate.json",
        "label": "Aggregerad blankning JSON",
        "url": "short-aggregate.json"
      },
      {
        "filename": "manifest.json",
        "label": "Hämtningsmanifest JSON",
        "url": "manifest.json"
      }
    ]
  },
  "llms_url": "/company/alligator-bioscience/llms.txt",
  "json_url": "/company/alligator-bioscience/company.json",
  "document_index_url": "/company/alligator-bioscience/documents.json",
  "absolute_url": "https://spela.port0.org/company/alligator-bioscience"
}